Form 4: Hims & Hers Health Director Christopher Payne Acquires 110,000 Shares
SEC Form 4 Filing
Director Christopher Payne purchased 110,000 shares of Hims & Hers Health, Inc. at an average price of $17.7433 on May 21, 2024.
Summary
- On May 21, 2024, Christopher D. Payne, a director of Hims & Hers Health, Inc., acquired 110,000 shares of Class A Common Stock.
- The shares were purchased at an average weighted price of $17.7433, with individual prices ranging from $17.64 to $17.855.
- The shares are held indirectly by The Payne Family Trust dtd 09/17/2020.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the director's significant share purchase, suggesting confidence in the company's future. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored as an indicator of management's sentiment about the company's prospects, relative to the broader market and industry trends.
Stakeholder Impact
- The share purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/17/2020 | Date of The Payne Family Trust |
| 05/21/2024 | Date of transaction: Christopher Payne purchased 110,000 shares of Hims & Hers Health, Inc. |
| 05/22/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.